HCPCS Level IIdrugActive
J7205
Factor viii fc fusion recomb
BETOS: O1E
Effective: 2016-01-01
Referenced in 5 policies
Description
Injection, factor viii fc fusion protein (recombinant), per iu
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Eloctate
Manufacturer
Bioverativ Therapeutics Inc.
HCPCS Dosage
1 IU
Billing Units
1.0000
10
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.